Insider Trading History of Price Fredric D

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Price Fredric D since 2007. The trader's CIK number is 1248094. At the time of the last reporting, Price Fredric D was the Director of Pharmasset Inc. (stock ticker symbol VRUS). Also see all insider trading activities at Pharmasset Inc.

Note that in the past PRICE FREDRIC D also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Pharmasset Inc (VRUS) by Price Fredric D

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2010 VRUS 0 $0 0 $0 1,668 $9,082
2009 VRUS 0 $0 0 $0 24,998 $136,113

Yearly summary of insider trading at Omrix Biopharmaceuticals, Inc. (OMRI) by Price Fredric D

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 OMRI 0 $0 49,000 $1,656,199 49,000 $303,163


Insider trading activities at 2 companies by Price Fredric D:

1. Pharmasset Inc (VRUS)

2. Omrix Biopharmaceuticals, Inc. (OMRI)

Table 1. Insider trading of Pharmasset Inc (VRUS) by Price Fredric D

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2010-03-03 VRUS Option Ex 1,668 5.45 9,082
2009-12-04 VRUS Option Ex 1,666 5.45 9,071
2009-09-02 VRUS Option Ex 1,666 5.45 9,071
2009-06-01 VRUS Option Ex 21,666 5.45 117,971

Table 2. Insider trading of Omrix Biopharmaceuticals, Inc. (OMRI) by Price Fredric D

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-06-04 OMRI Sale 49,000 33.80 1,656,199
2007-06-04 OMRI Option Ex 49,000 6.19 303,163

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Price Fredric D (Director of Pharmasset Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.